A plain language summary of the CAPItello-291 study: Capivasertib in hormone receptor-positive advanced breast cancer
- Nicholas C Turner
- , Mafalda Oliveira
- , Sacha J Howell
- , Florence Dalenc
- , Javier Cortés
- , Henry L Gomez
- , Xichun Hu
- , Komal Jhaveri
- , Petr Krivorotko
- , Sibylle Loibl
- , Serafin Morales Murillo
- , Yeon Hee Park
- , Joo-Hyuk Sohn
- , Masakazu Toi
- , Eriko Tokunaga
- , Samih Yousef
- , Lyudmila Zhukova
- , Elza de Bruin
- , Lynda Grinsted
- , Gaia Schiavon
- Vall D'Hebron Institute of Oncology
- IUCT Oncopole
- International Breast Cancer Center (IBCC)
- Instituto Nacional de Enfermedades Neoplásicas (INEN)
- Fudan University Shanghai Cancer Center
- Memorial Sloan Kettering Cancer Center
- N.N. Petrov National Medical Research Institute of Oncology
- GBG Forschungs GmbH (German Breast Group)
- Institut de Recerca Biomèdica Lleida
- Sungkyunkwan University
- Yonsei University College of Medicine
- Kyoto University Hospital
- National Hospital Organization Kyushu Cancer Center
- Emek Medical Center
- The Loginov Moscow Clinical Scientific Center
- University of California
Research output: Contribution to journal › Article › peer-review